BBNX
Beta Bionics, Inc. Common Stock
NASDAQ: BBNX · HEALTHCARE · MEDICAL DEVICES
$9.90
-1.79% today
Updated 2026-04-29
Market cap
$441.16M
P/E ratio
—
P/S ratio
4.00x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$9 – $33
Volume
1.2M
Beta Bionics, Inc. Common Stock (BBNX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | $35.53M | $110.04M | $149.65M | $328.74M |
| Cash & equivalents | $27.68M | $26.57M | $30.43M | $31.68M |
| Current assets | $28.47M | $103.62M | $132.92M | $267.90M |
| Total liabilities | $22.53M | $51.43M | $73.63M | $39.59M |
| Current liabilities | $8.87M | $10.61M | $21.15M | $30.92M |
| Long-term debt | — | — | — | — |
| Shareholder equity | $13.00M | $58.61M | $76.01M | $287.61M |
| Retained earnings | $-185.56M | $-229.66M | $-296.74M | $-369.94M |
| Accounts receivable | $0.00 | $4.45M | $12.00M | $17.12M |
| Inventory | $0.00 | $1.25M | $13.32M | $21.72M |
| Goodwill | — | — | — | — |